Advertisement
Scancell Holdings plc

Scancell Holdings plc (SCNLF) Stock Overview

Explore Scancell Holdings plc’s financial performance, market position, analyst ratings, and future outlook.

SCNLFPNK
HealthcareBiotechnology
$0.33
$0.00(0.00%)
U.S. Market opens in 7h 36m
Advertisement

Scancell Holdings plc (SCNLF)

Meyka AI Score

Z

Key Financials

Market Cap347.5M
P/E Ratio-47.10
EPS (TTM)$-0.01
ROE0.90%
Fundamental Analysis

AI Price Forecasts

1 Month$0.18
3 Months$0.21
1 Year Target$0.16

SCNLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Scancell Holdings plc (SCNLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 93.23, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.16.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -47.10 and a market capitalization of 347.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
46.87%
3-Month Change
115.21%
6-Month Change
132.55%
Year-to-Date (YTD) Change
132.55%
1-Year Change
97.21%
3-Year Change
52.21%
5-Year Change
33.95%
All-Time (Max) Change
-25.58%

Contact Information

44 18 6558 2066
Bellhouse Building, Oxford, NaN, OX4 4GD

Company Facts

61 Employees
IPO DateAug 2, 2013
CountryGB
Actively Trading

Frequently Asked Questions